Madison Avenue Partners as of March 31, 2024
Portfolio Holdings for Madison Avenue Partners
Madison Avenue Partners holds 18 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Graham Hldgs Com Cl B (GHC) | 26.1 | $162M | 211k | 767.68 | |
| Sharkninja Com Shs (SN) | 18.2 | $113M | 1.8M | 62.29 | |
| Theravance Biopharma (TBPH) | 10.1 | $63M | 7.0M | 8.97 | |
| Wiley John & Sons Cl A (WLY) | 8.4 | $52M | 1.4M | 38.13 | |
| Hess (HES) | 7.4 | $46M | 300k | 152.64 | |
| Stagwell Com Cl A (STGW) | 7.2 | $45M | 7.1M | 6.22 | |
| Globus Med Cl A (GMED) | 6.1 | $38M | 703k | 53.64 | |
| Nelnet Cl A (NNI) | 4.4 | $28M | 290k | 94.65 | |
| Homestreet (HMST) | 2.2 | $14M | 905k | 15.05 | |
| 2seventy Bio Common Stock (TSVT) | 2.1 | $13M | 2.4M | 5.35 | |
| Ovid Therapeutics (OVID) | 1.8 | $11M | 3.6M | 3.05 | |
| Orion Office Reit Inc-w/i (ONL) | 1.5 | $9.2M | 2.6M | 3.51 | |
| Franklin Street Properties (FSP) | 1.2 | $7.5M | 3.3M | 2.27 | |
| Merrimack Pharmaceuticals Com New | 0.9 | $5.7M | 387k | 14.77 | |
| Gossamer Bio (GOSS) | 0.8 | $4.9M | 4.1M | 1.18 | |
| Central Europe and Russia Fund (CEE) | 0.6 | $4.0M | 423k | 9.52 | |
| Indivior Ord (INDV) | 0.6 | $3.5M | 163k | 21.42 | |
| Atmus Filtration Technologies Ord (ATMU) | 0.4 | $2.5M | 77k | 32.25 |
